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VascularizationObjectives: The purpose of this study was to assess three-dimensional placental power Doppler indices in
second and third trimester of pregnancies complicated by chronic-, gestational hypertension or pre-
eclampsia.
Methods: We analyzed 226 pregnancies prospectively measuring three-dimensional placental power
Doppler indices (vascularization index, flow index, vascularization flow index) in cases of normal blood
pressure (N = 109), chronic hypertension (N = 43), gestational hypertension (N = 57) and pre-eclampsia
(N = 17). We evaluated the correlation among vascularization indices, flow characteristics of uterine
arteries and perinatal outcome. We assessed the influence of maternal factors (pregestational body mass
index, previous pregnancies/deliveries, maternal age) on vascularization indices, and analyzed histolog-
ical findings of placenta from pregnancy hypertension groups.
Results: Vascularization index was significantly higher (p = 0.010) in pregnancies with chronic- and lower
(p = 0.152) in pregnancies with gestational hypertension and preeclampsia compared to the normal
group. Flow index was significantly lower in all three pathological groups compared to normal group.
Placental volume was significantly smaller (p < 0.001) in all three pathological groups than in normal
pregnancies at the time of delivery, and there was no significant difference between the three affected
groups. The rate of adverse pregnancy outcomes showed no significant difference between the normal
and chronic hypertension groups. We observed significantly lower 10 , 50 and 100 APGAR scores
(p < 0.,001), and birth weight in preeclampsia compared to chronic-, gestational hypertension, and nor-
mal groups. Maternal factors had no influence on the development of the power Doppler indices.
Conclusion: Vascularization indices seem good markers for the prediction of risks and adverse outcomes
in case of pregnancy hypertension.
 2017 Published by Elsevier B.V. on behalf of International Society for the Study of Hypertension in
Pregnancy.1. Introduction
Hypertension during pregnancy affects 5–7% of all pregnancies
and approximately 70% of cases occur in first-time pregnancies [1].
The incidence of chronic hypertension (CHT) among pregnantwomen is 1–2%, while gestational hypertension (GHT) complicates
3–6% of all cases showing a rising tendency in recent years [1,2]. It
is a prominent cause of maternal and fetal morbidity and mortal-
ity; however, its pathophysiological background is poorly under-
stood [3]. Most patients have no clinical symptoms, but it is
important to emphasize that hypertension is merely one manifes-
tation, i.e., the first stage of pre-eclampsia (PE).
Proper uterine and placental vascularization is important for
the adequate development of pregnancies [4]. Pathological fetoma-
ternal circulation can lead to elevated resistance in uterine circula-
tion, which can cause placental insufficiency [5,6] and thus – due
to pathological development of the placenta – result in premature
birth, intrauterine hypoxia, or even intrauterine death [7,8].nd and
’s Card.
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allowed us to obtain and study volumes from different organs, such
as the human placenta more precisely [9], and the color map pro-
vided by power Doppler has made the study of vessels with low
resistance much easier [10]. The combination of these techniques
has made it possible to study the morphology of the vascular tree
and to quantify the total blood flow of the placenta [11].
The purpose of the present investigation was to reveal changes
in vascularization and their effects on perinatal outcome using
Doppler indices of uterine arteries and placental vascularization
during the second and third trimester.
Our hypothesis was that despite ongoing antihypertensive
treatment placental vascularization and placental volume do differ,
depending on the etiology of hypertension (CHT or GHT). We
aimed to explore the causes affecting placental volume and vascu-
larization, and analyzed the influence of gestational (placental vol-
ume, gestational age, flow characteristics of umbilical and uterine
arteries, perinatal outcome and complications) as well as maternal
characteristics (maternal age, pregestational body mass index
(BMI), previous pregnancies and deliveries) on placental
vascularization.2. Materials and methods
Women with singleton pregnancies who presented for routine
ultrasound between September 2014 and November 2015 once
in the second or third trimester at the Department of Obstetrics
and Gynecology, University of Szeged were enrolled in our
prospective cohort study, which was carried out in accordance
with the Code of Ethics of the World Medical Association (Declara-
tion of Helsinki) for research involving humans. We received
informed consent from each participant, and our study was
approved by the institutional research ethics committee (No.:
32/2014).
Pregnancies enrolled during the examination period were
divided into four groups: normal blood pressure as control group
(NBP) (NNBP = 109), patient group consisting of pregnancies com-
plicated by chronic hypertension (NCHT = 43), pregnancies compli-
cated by gestational hypertension (NGHT = 57) and pregnancies
complicated by pre-eclampsia (NPE = 17). It was not our goal to
include similar number of patients in each study group, but to
include as many gestational hypertension cases detected during
the study-period as possible.
Exclusion criteria included multiple pregnancies; thrombophil-
ia, molar pregnancy, structural or chromosomal anomaly and fetal
abnormalities (with 1 month follow-up after delivery); placenta
praevia; self-reported drug, alcohol, caffeine or nicotine abuse;
exposure to circulatory medications (calcium dobesilate); systemic
diseases (such as diabetes mellitus, vasculitis, etc.).
We specified high blood pressure on the basis of the Interna-
tional Society for the Study of Hypertension in Pregnancy [12]
(140 mmHg systolic and/or 90 mmHg diastolic). During blood
pressure measurement patients were seated comfortably, their
arm was relaxed, uncovered, supported at the level of the heart,
and their arm circumference was also measured to use the proper
cuff size. Blood pressure was measured three times (BP A100 PLUS,
Microlife AG, Windau, St. Gallen, Switzerland) on each occasion,
and patients were scheduled for a check-up every two weeks.
The patients were prepared for self-control blood pressure mea-
surement as well.
All patients of the three pathological groups had ongoing anti-
hypertensive therapy via oral administration of 250 mg alpha-
methyldopa (Dopegyt, EGIS Pharmaceuticals PLC., Budapest, Hun-
gary) and dietary salt restriction at the time of inclusion.Please cite this article in press as: A. Surányi et al., Evaluation of placental vas
third trimester of pregnancies complicated by chronic hypertension, gestation
Health (2017), http://dx.doi.org/10.1016/j.preghy.2017.03.004High blood pressure prior to pregnancy was determined as
inclusion criteria for CHT [12]. New onset of hypertension after
20 weeks of gestation was an inclusion criterion for GHT, and
NBP was documented both before pregnancy and during the entire
pregnancy period [12]. Patients in the pre-eclampsia group (PE)
had high blood pressure during gestation associated with protein-
uria or intrauterine growth restriction [12].
Body mass index (BMI) was defined as underweight if <19 kg/
m2 and as obese if >29 kg/m2.
2.1. Management of the examinations
All patients were scanned in a semi recumbent position by the
same sonographer with the help of Voluson 730 system (RAB 2-
5 MHz transducer; GE Healthcare Austria, Tiefenbach, Austria).
Same instrumental settings were used in all cases (‘Obstetrics/2–
3 trimester’ in 2D mode). An initial two-dimensional conventional
examination provided data about fetal position, body movements
and fetal heart rate, placental localization, insertion of umbilical
cord, the volume of amniotic fluid and fetal biometry according
to the formula B of Hadlock [13], followed by two-dimensional
color Doppler investigation of uterine arteries [14], where pulsatil-
ity index (PI) was measured as well [15].
2.2. Volume acquisition
We used 3D rendering mode, in which the color and gray value
information was processed and combined to give 3D image (mode
cent: smooth, 4/5; FRQ: low; quality: 16; density: 6; enhance: 16;
balance: 150; filter: 2; actual power: 2 dB; pulse repetition fre-
quency: 0.9). Power Doppler window (pulse repetition frequency
at 900 Hz and wall filter of 50 Hz) was placed over the placenta,
mapping the vascular tree from basal to chorionic plates. This tech-
nique produces higher sensitivity, because it is based on amplitude
instead of mean frequencies, unlike color Doppler to depict the
vascular tree [10]. Moreover, color mapping is independent from
the angle of insonation and does not show ‘aliasing’ [10,16,17].
The 3D static volume box was placed over the highest villous vas-
cular density zone at umbilical cord insertion [8,18]. We used low
resolution acquisition to avoid any kind of artifacts [18].
2.3. Calculation of three-dimensional power Doppler indices (3-DPD)
Volume files were analyzed using virtual organ computer-aided
analysis (VOCAL) software (4D View Version 10.4, GE Healthcare
Austria, Tiefenbach, Austria) by an expert in 3D analysis.
We used Mercé-type placental sonobiopsy (see Fig. 1), a repro-
ducible, validated method for obtaining representative sample of
the placental tree, which – contrary to other methods – is applica-
ble throughout the whole pregnancy when the entire placenta
needs to be visualized [18,19]. This method is a valid alternative
for the evaluation of the placental vascular tree when visualization
of the entire placenta is not possible [20]. The spherical sample vol-
ume was constantly 28 ml. Color scale values were calculated
automatically in a histogram by VOCAL software from the acquired
spherical sample volume in all cases [8,18]. Two-dimensional and
three-dimensional acquisitions were performed at the same time,
and 3D volume files were analyzed by VOCAL software at a later
time.
2.4. Statistical analysis
Statistical analyses were performed by IBM SPSS Statistics 21.0
for Windows (IBM, New York, USA). Kolmogorov–Smirnov test
results were significant for our database demonstrating that our
study samples were not normally distributed. Kruskal–Wallis testscularization by three-dimensional ultrasound examination in second and
al hypertension or pre-eclampsia, Preg. Hyper: An Int. J. Women’s Card.
Fig. 1. Interface of VOCAL software presenting placental sonobiopsy at umbilical cord insertion (32nd week of gestation).
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the four groups (CHT versus NBP; GHT versus NBP; PE versus
NBP), whereas comparison between the three pathological groups
(CHT versus GHT; GHT versus PE) was assessed with Mann–Whit-
ney U test. Univariate comparisons for categorical variables were
assessed by v2 tests. Linear regression coefficient values and equa-
tions depending on gestational age were also calculated for VI, FI,
and VFI in case of pathological and control groups. Association
between placental 3-DPD indices, maternal and fetal characteris-
tics, two-dimensional color Doppler indices (PIs of umbilical and
uterine arteries) were determined by Spearman’s rank correlations
and the multivariate relationship was analyzed using quantile
regression.
2.5. Histological analysis
Histological analysis of placentae following delivery were per-
formed in 18 cases of pregnancy hypertension/5 CHT, 8 GHT and
5 PE/. Histological preparations were made on the basis of the rec-
ommendation of The Royal College of Pathologists, UK. [21] We
applied AxioVision SE64 Rel. 4.9.1 program for assessing slides.Table 1
Mean value and standard deviation (SD) of 3-dimensional po
FI: flow index, VFI: vascularization flow index) and the rate
chronic hypertension (CHT), gestational hypertension (GHT) a
CHT
(N=43)
NBP
(N=109
VI
(mean ± SD)
14.42 ± 10.12 10.36 ± 6
FI
(mean ± SD)
41.51 ± 8.15 46.08 ± 7
VFI
(mean ± SD)
3.61 ± 2.81 4.08 ± 2.
Early diastolic 
notch
1/44 (2.27%) 0/146 (0%
p=0.010
p=0.009
p=0.973
p=0.126
p=0.001
p=0.141
p=0.002
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The analysis of 3D volume acquisition demonstrated that VI
indices are significantly higher in CHT group (p = 0.010) compared
to NBP. In case of GHT, VI was lower compared to NBP (p = 0.152)
group, though the difference was not statistically significant. There
was significant difference (p < 0.001) between CHT and GHT
groups.
All PE cases evolved from GHT cases, therefore we analyzed the
changes in 3-DPD indices, but the difference between GHT and PE
groups in case of VI was not statistically significant (p = 0.175).
FI was significantly lower in all pathological groups compared
to NBP group (in case of CHT p = 0.009, in case of GHT and PE
p < 0.001). There was no statistically significant difference between
CHT and GHT (p = 0.296) and GHT and PE (p = 0.183) groups.
Significantly different VFI was found between CHT and GHT
groups and when PE group was compared to NBP group, respec-
tively (see details in Table 1).
Spearman rank order correlation test was utilized for seeking
correlation between 3-DPD indices and birth weight. Strong linear
correlation was found between VI, FI and birth weight (p = 0.002).wer Doppler (3-DPD) indices (VI: vascularization index,
of early diastolic notch in normal blood pressure (NBP),
nd pre-eclampsia (PE) with level of significance.
)
GHT
(N=57)
PE
(N=17)
.19 7.73 ± 7.07 4.86 ± 3.22
.75 38.50 ± 9.60 36.5 ± 5.71
51 3.02 ± 2.45 1.99 ± 1.6
) 3/38 (7.89%) 6/17 (36.29%)
p=0.152
p=0.000
p=0.075
p=0.175
p=0.183
p=0.128
p=0.004 p=0.012
cularization by three-dimensional ultrasound examination in second and
al hypertension or pre-eclampsia, Preg. Hyper: An Int. J. Women’s Card.
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or lower than 2.6 intrauterine growth restriction (IUGR) – and
according to ISSHP’s revised statement [12] progression to PE – will
develop.Mean FI was 45.7 in case of normal pregestational-BMI and
41.2 in case of elevated BMI, thus elevated pregestational-BMI had
substantial influence on FI depression (p < 0.05) and fetal growthTable 2
Maternal characteristics of pregnancies with normal b
gestational hypertension (GHT) and pre-eclampsia (PE).
CHT
(N=4
Mean maternal age (mean ± SD) 32.8 ± 
Weeks of gestation
at the time of 3D sweep (mean ± SD)
28+5 ± 
Weeks of gestation 
at the time of delivery (mean ± SD)
38+4 ± 
Premature birth 3/43
(4.76%
Pregestational-BMI (kg/m²) 31.8 ± 
Previous pregnancies None 14/4
(34.88
One 12/4
(27.90
Two or more 17/4
(39.53
Previous deliveries None 17/4
(39.53
One 17/4
(39.53
Two or more 9/43
(20.93
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Health (2017), http://dx.doi.org/10.1016/j.preghy.2017.03.004development, consequently on birth weight. The placental volume
at the time of delivery was significantly (p < 0.001) smaller in
GHT, CHT and PE groups than in NBP, but there was no significant
difference between the pathological groups.
Early diastolic notch findings are presented in Table 2. The
number of previous pregnancies and deliveries in each group islood pressure (NBP), chronic hypertension (CHT),
Significant differences are highlighted.
3)
NBP
(N=109)
GHT
(N=57)
PE
(N=17)
4.2 30.7 ± 4.7 31.1 ± 5.4 29.2 ± 5.4
6+6 24+6 ± 7+2 30+2 ± 6+2 31+4 ± 5+9
1+4 38+3 ± 1+6 38+1 ± 2+3 37+2 ± 2+4
 
)
8/109 
(7.33%)
7/57 
(12.28%)
5/17
(29.41%)
4.6 30.7 ± 5.2 31.0 ± 5.0 27.2 ± 6.1
3 
%)
35/109 
(32.11%)
16/57
(28.07%)
6/17
(35.29%)
3
%)
37/109 
(33.94%)
27/57
(47.36%)
4/17
(23.52%)
3 
%)
38/109 
(34.86%)
14/57
(24.56%)
7/17
(41.17%)
p<0.001
p<0.001p<0.001
p<0.001p<0.001
p<0.001
3 
%)
51/109  
(46.78%)
33/57 
(57.89%)
7/17
(41.17%)
3 
%)
38/109
(34.86%)
20/57  
(35.08%)
6/17
(35.29%)
 
%)
20/109
(18.34%)
4/57
(7.01%)
4/17
(23.52)
p<0.001p<0.001p<0.001
p<0.001
cularization by three-dimensional ultrasound examination in second and
al hypertension or pre-eclampsia, Preg. Hyper: An Int. J. Women’s Card.
Table 3
Perinatal characteristics and pregnancy outcome in cases of normal blood pressure (NBP), chronic hypertension
(CHT), gestational hypertension (GHT), and pre-eclampsia (PE). Significant differences are highlighted.
CHT
(N=43) 
NBP
(N=109)
GHT
(N=57)
PE
(N=17)
Apgar score 
(mean ± SD)
1' 8.92±1.11 9.07±1.50 8.68±1.51 8.38±1.47
5' 9.71±0.83 9.70±0.95 9.61±0.72 9.38±1.38
10'
9.92±0.34 9.83±0.77 9.82±0,60 9.61±0.80
Umbilical pH
(mean ± SD)
7.22±0.07 7.26±0.07 7.26±0.07 7.25±1.05
Perinatal complications Apnea 3/43
(6.97%) 
9/109 
(8.25%) 
6/57 
(10.52%) 
7/17
(41.17%) 
Polycythemia 2/43
(4.64%) 
7/109
(6.42%) 
7/57 
(12.28%) 
2/17
(11.76%) 
Hypoglycemia 1/43 2/109 2/57 3/17
p<0.001p<0.001
p<0.001
p<0.001
p<0.001
p<0.001
(2.32%) (1.83%) (3.50%) (17.64%)
Respiratory 
distress 
syndrome
0/43
(0%)
0/109
(0%)
0/57
(0%)
3/17
(17.64%) 
Dysmaturity 0/43
(0%)
3/109
(2.75%) 
4/57
(7.01%) 
12/17
(70.58%) 
Feeding 
difficulties
1/43 
(2.32%) 
7/109
(6.42%) 
4/57 
(7.01%) 
0/17
(0%)
Parenteral
administratio
n of ampicillin
4/43
(9.30%) 
1/109
(0.91%) 
4/57
(7.01%) 
5/17
(29.41%) 
Birth weight
(g) 
3377±374 3346±555 3236±751 2422±817
Male/female ratio 32.5%/67.5% 47.7%/52.3% 54.3%/45.7% 35.3%/64.7%
p<0.001
p<0.001p<0.001p<0.001
p<0.001
p<0.001
p<0.001
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Table 4
Effects of maternal and fetal characteristics on placental vascularization indices in case of pregnancy hypertension (chronic-, gestational hypertension and preeclampsia cases
examined as one)* – statistical methods used, and level of significance (N.S.: no significant difference, S.: significant difference was found).
Table 4 Statistical method VI FI VFI p-value
Gravidity ANOVA N.S. N.S. N.S. <0.001
Parity ANOVA N.S. N.S. N.S. <0.001
Pregestational BMI (normal) ANOVA N.S. N.S. N.S. <0.04
Pregestational BMI (obese) ANOVA N.S. N.S. N.S. <0.04
Pregestational BMI (excessive weight gain)** ANOVA N.S. N.S. N.S. <0.04
Umbilical cord arterial pH Student’s t test N.S. S N.S. <0.001
1-minAPGAR score Mann-Whitney test N.S. N.S. N.S. <0.47
5-minAPGAR score Mann-Whitney test S. S. S. <0.04
10-minAPGAR score Mann-Whitney test S. S. S. <0.046
Birth Weight Student’s t test S. S. S. <0.01
Estimated Fetal Weight Student’s t test S. S. S. <0.01
Placental localisation Student’s t test N.S N.S. N.S. <0.04
* There was no significant difference between the pathological groups.
** Normal BMI pregestationally with excessive weight gain during pregnancy.
6 A. Surányi et al. / Pregnancy Hypertension: An International Journal of Women’s Cardiovascular Health xxx (2017) xxx–xxxrecorded in Table 3. Risk estimation for perinatal complications
(such as apnea, respiratory distress syndrome (RDS), hypo-
glycemia, polycythemia, dysmaturity, feeding difficulties etc.)
was also analyzed by using Wilcoxon rank-sum test. FI value was
found prognostic for umbilical pH and birth weight, but there
was no difference between CHT, GHT or PE groups (see details in
Table 3).
We found that BMI and other maternal characteristics had no
effect on placental vascularization indices in pregnancies either
complicated by hypertensive disorder or not (see Table 4).
There was correlation (p < 0.05) between NOTCH detected and
pregnancy outcome as in case of NOTCH the chance of caesarean
section was 65% in CHT, 77% in GHT, and 100% in PE, although
we found no correlation between uterine artery PI and adverse
pregnancy outcome rates.
We applied non-parametric analysis to compare three or four
groups, and Mann-Whitney U test was used to compare the patho-
logical groups.Table 5
Histological characteristics of 18 placentas, in case of pregnancy hypertension/5
Chronic Hypertension, 8 Gestational Hypertension, 5 Preeclampsia/, that have been
analyzed following delivery.
Histological characteristics of placentae
with pregnancy hypertension
CHTN = 5 GHTN = 8 PEN = 5
Neutrophil invasion: 0/5 0/5 0/5
Interstitial fibrosis:
-No 5/5 4/8 0/5
-Mild 0/5 4/8 3/5
-Moderate 0/5 0/8 2/5
-Severe 0/5 0/8 0/5
Vascularization:
-Normovascularized 3/5 0/8 0/5
-Hypovascularized 2/5 8/8 5/5
Parenchymal haematoma: 2/5 6/8 3/5
Fibrin deposits: 2/5 4/8 5/5
Syncytial knots:
-Yes 2/5 3/8 0/5
-Moderate 3/5 2/8 3/5
-Severe 0/5 3/8 2/5
Calcification:
-None 3/5 0/8 0/5
-Peripheral 1/5 4/8 0/5
-Focal 1/5 4/8 5/5
Chorioamnionitis: 0/5 1/8 0/5
Funisitis:
/same patient that had
chorioamnionitis/
0/5 1/8 0/5
Villiitis: 0/5 0/8 0/5
Accelerated maturation: 1/5 6/8 5/5
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Health (2017), http://dx.doi.org/10.1016/j.preghy.2017.03.004Table 5 shows the main histological characteristics of each
pathological group. Vasculopathy was only seen in 2/5 PE placen-
tae, all PE cases were IUGR and two of them have been delivered
preterm. Fig. 2 shows a normal blood pressure placenta, and
Fig. 3 shows a placenta from a preeclamptic patient.4. Discussion
Placental vascularization was investigated in our 2nd–3rd tri-
mester in vivo study while most publications describe only 1st tri-
mester data, and was found to be significantly lower in gestational
hypertension compared to normal blood pressure.
A common pathological feature of GHT is the failure of maternal
arteries supplying placenta to undergo histological adaptations of
normal pregnancy that facilitate adequate placental perfusion
[22,23].
In CHT cases involving predisposed pregnant women and nor-
mal placenta, maternal scavenging system takes part in patholog-
ical regulation of maternal blood pressure. This may lead to
inadequate response of these systems, resulting in an overload
and defect even if the vascular system of the placenta is normal.
Since placenta has normal growth patterns in CHT, the develop-
ment and malfunctions of maternal systems evolve more slowly
than in GHT or PE. In our CHT cases placental growth was close
to normal, which led to the development of milder clinical symp-
toms and perinatal complications than in GHT and especially in
PE cases. Premature birth rate was almost 2.57 higher in GHT
and 6.17 times higher in PE compared to CHT. GHT cases with IUGR
were involved and no proteinuria could be detected because of
antihypertensive therapy. It means that antihypertensive therapy
protects maternal renal function, but placental vascularization
can be destroyed [12].
In GHT cases comprising women with normal medical condition
before pregnancy and dysfunctional placenta, the scavenging sys-
tem of these pregnant women can cope with these deleterious
changes in the placenta in the early period of gestation, then
GHT and incidentally PE may develop. Clinical symptoms may only
develop subsequently during pregnancy. Concurrently, maternal
endothelium is affected only late in pregnancy and thus changes
in placental vascularization are mostly related to PE (GHT compli-
cated by IUGR [12]) rather than to CHT [24,25]. In this case, the
fetus mostly develops into an abnormally grown baby. IUGR rate
was 22.97% among GHT cases (17/74), which shows the progress
rate to PE, although proteinuria and other dysfunction of maternal
organs, such as renal insufficiency, liver dysfunction and neurolog-
ical or hematological complications did not appear [12].cularization by three-dimensional ultrasound examination in second and
al hypertension or pre-eclampsia, Preg. Hyper: An Int. J. Women’s Card.
Fig. 2. Histological sample of normal placenta. Haemtoxylin-eosin staining, magnification 40.
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tors into maternal circulation leading to maternal symptoms, as
failed conversion of spiral arteries limits normal maternal blood
flow [26] and it seems that neither the fetus, nor the uterine mus-
cle has a role in the development of the disorder, which resolves
following delivery.
We found that in second and third trimesters placental vascu-
larization is even more significantly lower in hypertension com-
pared to NBP cases despite ongoing antihypertensive treatment,
than in first trimester [27].
Regarding CHT, significantly higher VI revealed elevated vascu-
larization rate, because this is the placental vascular response to
elevated maternal blood pressure. Significantly lower FI rate, sug-
gests partial insufficiency of this process. There was no significant
difference in adverse pregnancy outcome rates between CHT and
NBP, which enhances the possibility of an underlying compen-
satory mechanism. This compensatory mechanism may be respon-
sible for increased VI in pregnancies complicated by CHT. It seems
that chronic hypertension leads to lower FI and higher VI during
early stages of pregnancy thus the placenta may have the ability
to compensate, though sometimes this compensatory mechanism
is inadequate. We can highlight that CHT cases have similar pla-
cental blood perfusion to NBP cases, which is supported by the
higher VI and lower FI rates and the similar adverse pregnancy out-
come rates.
Our results showed lower VI in pregnancies complicated by
GHT and PE compared to NBP group, though the difference wasPlease cite this article in press as: A. Surányi et al., Evaluation of placental vas
third trimester of pregnancies complicated by chronic hypertension, gestation
Health (2017), http://dx.doi.org/10.1016/j.preghy.2017.03.004not significant. Similarly to Guiot et al. [28] and Odeh et al. [29],
FI was statistically significantly lower in GHT and in PE groups
compared to NBP group. We can highlight that GHT and PE cases
have less placental blood perfusion than CHT or NBP, which is sup-
ported by lower VI and FI rates.
We found that placental vascularization indices in case of NBP
were biostatistically constant during pregnancy. In pregnancies
complicated by hypertensive disorders placental vascularization
indices were decreased during pregnancy, but the registered
decrease was not significant.
The fetal characteristic features of hypoxia were not elevated in
CHT and GHT patients compared to NBP patients. Occurrence of
apnea was about 4 times higher, while hypoglycemia was about
5 times higher in PE compared to all other groups. Since hyperten-
sion during pregnancy is determined by different maternal factors,
we emphasize the influence of pregestational-BMI and primigra-
vidity/primiparity. In case of elevated pregestational-BMI, FI
decreased significantly in all three pathological groups. Primiparity
has a definite role in the development of GHT. Primiparity ratio
was 57.8% in GHT and 37.2% in CHT. Furthermore, in second or
third pregnancies the chance of CHT rises. In our study, GHT was
35% for the second gestation, 7.2% for the third or higher number
gestations. In the CHT group, the prevalence of two earlier preg-
nancies was 39.5% and the prevalence of three or more was 23.3%.
The male/female ratio was different between CHT and GHT in
our study. Severe placental dysfunction is more common in preg-
nancies with a male infant than with female one [30]. This is alsocularization by three-dimensional ultrasound examination in second and
al hypertension or pre-eclampsia, Preg. Hyper: An Int. J. Women’s Card.
Fig. 3. Histological sample of preeclamptic placenta with intra uterine growth restriction. Small terminal villi, with villous hypoplasia, Haemtoxylin-eosin staining,
magnification 40.
8 A. Surányi et al. / Pregnancy Hypertension: An International Journal of Women’s Cardiovascular Health xxx (2017) xxx–xxxconfirmed by our data, because male/female ratio was 54.3% versus
45.7% in GHT, while it was 32.3% versus 67.5% in CHT presenting
female dominance compared to the normal distribution of the con-
trol group (47.7% versus 52.3%).
In spite of the fact that alpha-methyldopa therapy and dietary
salt restriction were already ongoing at the time of inclusion, we
found significant differences in placental vascularization between
the three pathological groups in second and third trimester, which
shows the partial effectiveness of antihypertensive therapy and the
potential risk of progression to PE. Although Noguchi et al. [31]
found that 3-DPD placental vascularization indices at 18–22 weeks
could not be used to predict high-risk pregnancies that develop
GHT in a low-risk population, our results showed their usefulness
probably because of the difference in the weeks of gestation and
the number of cases examined.
We have still insufficient amount of data on possible correla-
tions of Doppler analyses to clinical biomarkers of CHT, GHT and/
or PE, such as soluble fms-like tyrosine kinase 1 (sFlt-1) or placen-
tal growth factor (PlGF) [32].5. Conclusions
Our goal was to examine placental vascularization in 2nd and
3rd trimester, on etiological basis. We found that in early detection
of PE, 3-DPD indices may be useful to prevent the most frequentPlease cite this article in press as: A. Surányi et al., Evaluation of placental vas
third trimester of pregnancies complicated by chronic hypertension, gestation
Health (2017), http://dx.doi.org/10.1016/j.preghy.2017.03.004fetal complications, thus we can make the decision about manage-
ment and monitoring strategy.
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